Study agents | Other agents | Disease | Dose | No Pts | Response | Reference |
---|---|---|---|---|---|---|
Crenolanib | Cytarabine Anthracycline | Untreated | 100 mg TID | 25 | CR 88% CR/CRi 96% | [62] |
Crenolanib | Cytarabine Anthracycline | Untreated | 100 mg TID | 29 | CR 83% | [63] |
Crenolanib | Cytarabine Mitoxantrone | Relapsed Refractory | 100 mg TID | 8 | CR 67% | [64] |
Crenolanib | Idarubicin Cytarabine | Relapsed Refractory | 60/80/100 mg TID | 13 | ORR 36% | [65] |
Crenolanib |  | Relapsed Refractory | 200 mg/m2/day | 10 | ORR 47% | [66] |